N
Patient 1
APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | I-STAT1 ANALYZER | I-STAT1 ANALYZER | ABBOTT POINT OF CARE | GKF | NA | 04P75-30 | NA | Y | R | |||
| 1 | I-STAT1 ANALYZER | I-STAT1 ANALYZER | ABBOTT POINT OF CARE | CGA | NA | 04P75-30 | NA | Y | R |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2018-03-02 | 0 |
Patient 1
APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.
Patient 1
ON (B)(6) 2018, AN ABBOTT POINT OF CARE DISTRIBUTOR WAS CONTACTED BY A CUSTOMER REGARDING AN I-STAT 1 ANALYZER THAT YIELDED SUSPECTED DISCREPANT HEMATOCRIT/HEMOGLOBIN RESULTS ON A PATIENT. THERE WAS NO PATIENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT. PRODUCT IS AVAILABLE FOR INVESTIGATION. (B)(6). THE CUSTOMER STATES THAT THE TESTS FOR I-STAT WERE DONE ON THE SAME PATIENT LESS THAN 3 HOURS APART. TEST/COLLECTION TIMES ARE UNK. THERE ARE NO INJURIES ASSOCIATED WITH THIS EVENT. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. THE INVESTIGATION IS UNDERWAY.